Biotech · Private company
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Track this companyFree. Adds K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials93 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- AzenosertibPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Investigator's choice of ChemotherapyPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- azenosertibPhase 2 · High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerClinicalTrials.gov · fetched Nov 12, 2026
- AzenosertibPhase 2 · Uterine Serous CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NiraparibPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- AzenosertibPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AzenosertibPhase 1 · OsteosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- EncorafenibPhase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 1 · OsteosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Pegylated liposomal doxorubicinPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ZN-c3Phase 1 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionPHASE3 · RECRUITING · started Apr 17, 2026ClinicalTrials.gov NCT07546500 · fetched Nov 12, 2026
- ZN-c3 + Gemcitabine in Pancreatic CancerPHASE2 · TERMINATED · started Nov 16, 2023ClinicalTrials.gov NCT06015659 · fetched Nov 12, 2026
- ZN-c3 in Adult Participants With Metastatic Colorectal CancerPHASE1 · TERMINATED · started Feb 27, 2023ClinicalTrials.gov NCT05743036 · fetched Nov 12, 2026
- A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerPHASE2 · RECRUITING · started Feb 17, 2022ClinicalTrials.gov NCT05128825 · fetched Nov 12, 2026
- A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian CancerPHASE1_PHASE2 · COMPLETED · started Jan 27, 2022ClinicalTrials.gov NCT05198804 · fetched Nov 12, 2026
- A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With OsteosarcomaPHASE1 · COMPLETED · started Aug 1, 2021ClinicalTrials.gov NCT04833582 · fetched Nov 12, 2026
- A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous CarcinomaPHASE2 · COMPLETED · started Jul 28, 2021ClinicalTrials.gov NCT04814108 · fetched Nov 12, 2026
- A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerPHASE1 · RECRUITING · started Oct 26, 2020ClinicalTrials.gov NCT04516447 · fetched Nov 12, 2026
- A Study of Azenosertib (ZN-c3) in Participants With Solid TumorsPHASE1 · COMPLETED · started Nov 1, 2019ClinicalTrials.gov NCT04158336 · fetched Nov 12, 2026